Aurigene Pharmaceutical Services provides a flexible and wide range of services and capabilities at each phase of drug lifecycle.
- End-to-end services across the drug lifecycle.
- Integrated services and resources enabling seamless and accelerated development from discovery to commercialization.
- Capabilities to supply from gram scale to multi-ton scale of active ingredients and complex intermediates.
- Core areas of competence in specialized chemistry (peptides, carbohydrates, steroids, mPEGs).
- Standalone and integrated discovery services.
- World-class infrastructure: State-of-the-art R and D and manufacturing facilities audited by major international regulatory agencies.
- Biotherapeutic modalities including proteins, antibodies, ADCs, CAR Ts, mRNAs.
- Drug product capabilities from formulation development to commercial production in GMP facilities.
Hit Generation
Lead
IdentificationLead
Optimization
- Early stage drug discovery accelerating innovations for small and large molecules.
- FTE/FFS services in medicinal chemistry, computational chemistry, discovery biology. and large molecule modalities.
Development
Phase 1Development:
Phase 2Development:
Phase 3
- Helping our partners to bring their innovations to the market faster through phase appropriate development services.
- Process development and non-GMP supplies and technology transfer.
- GMP clinical supplies for API and drug product.
Commercial
Manufacturing
- Ensuring a sustainable supply of APIs and finished formulations.
- Continuous improvement and reliable commercial supplies from 8 US FDA inspected facilities.
Range of our services
Aurigene Pharmaceutical Services offers end-to-end capabilities across drug discovery, development and manufacturing of APIs and formulations. We have discovery, development and manufacturing operations in multiple technology platforms including carbohydrates, steroids, PEG derivatives, oligonucleotides, steroids, high-potent APIs and peptides. In addition, we run discovery scale and CDMO scale operations in biotherapeutics services such as ADCs, mAbs, mRNAs and CAR Ts.
Aurigene Pharmaceutical Services CRO/CDMO
Small
Molecules
Large Molecules
Biotherapeutics
Formulation
Services
Formulation Services
Early phase formulation development, Preformulation, Drug product characterization studies and testing, Pharmaceutical stability studies
Why Aurigene Pharmaceutical Services?
Our focus on scientific expertise and integrated services along with our strong fundamentals on quality infrastructure, sustainability operations, and information security makes us a preferred partner.
Truly integrated services
We offer one-stop solutions for
- Integrated Discovery chemistry and Biology services
- Small molecule and Large molecule services
- Services from early discovery to commercialization
- Global regulatory and quality expertise
- Pre-formulation and formulation service
- Analytical and purification expertise
Quality
- Our R and D site is US FDA inspected cGMP sites have multiple accreditations across globe, All our labs are GLP approved, animal facilities are AAALAC accredited
Science
- Strong technology platforms Niche/Sensitive/Complex chemistry expertise
Infrastructure
- 2 R and D centers, 8 US FDA inspected cGMP sites, AAALAC accredited vivarium
Information Security
- 360-degree information security coverage with adequate back-up plan, business continuity plan and information security interventions
Business Continuity
- Structured assurance and governance measures
People
- We strive to hire the best talent and train them,
700+ scientists, >95% of scientists are post-graduates or above
ESG
- Commitment to highest standards of Environment, Social and Governance; Dow Jones, CDP, PSCI, approved
Connect with our scientific experts for your drug discovery, development, and manufacturing needs
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Learning Resources
Transforming Drug Discovery with Aurigene.AI
In the early 2000s, developing Sovaldi, a hepatitis C treatment, took over a decade and nearly $2 billion. Similarly, Zolgensma, a gene therapy for spinal muscular atrophy, required 15 years due to its complexity. However, the advent of artificial intelligence (AI) has revolutionized drug discovery. For example, in 2022, Pfizer's PAXLOVID, an oral COVID-19 treatm...
Read More
Advancement in personalized medicine and how the CRDMO industry is part of the solution
Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabli...
Read More
Overcoming challenges with cyclic peptides for In-vitro experiments and Bioanalysis
Project Requirement:Cyclic peptides were to be analyzed for Kinetic solubility, Chrom Log D, MDCK, PAMPA, & Caco2 experiments, while overcoming the challenges associated with the impact of cyclization of peptides on in vitro experiments and bioanalysisWhat were the challenges!1. Nonspecific Binding (NSB)2. Precipitation of peptides while spiking DMSO stock to...
Read More
Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques
2025
Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read More-
Development of novel paullone-based PROTACs as anticancer agents
Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read More -
A simple RP-HPLC method development and verification of the Dissolution of Bromelain-A Complex mixture of proteolytic enzymes, in delayed release tablets
Bromelain is a complex natural mixture of proteolytic enzymes derived from pineapple (Ananas cosmosus), which has good therapeutic properties. Bromelain can be found in all tissues of pineapple plants, including the stem, fruit, and leaves. Bromelain plays an important role in the treatment of many diseases such as soft tissue inflammation and edema, deep derma, ...
Read More -
A sensitive and a simple RP-HPLC method development and verification for the quantitative estimation of Cholecalciferol in tablets
Cholecalciferol, also known as Vitamin D3, is widely prescribed for the treatment osteomalacia and osteoporosis [1]. It also plays a key role in calcium and phosphorus homeostasis and skeletal mineralization [2]. IUPAC name of Cholecalciferol is (3β, 5Z, 7E) 9,10-secocholesta-5,7,10(19)-trien-3-ol, whose molecular weight is 384.64 g/mol and its molecular formula...
Read More
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market